Protalix BioTherapeutics
PLX
#8412
Rank
S$0.22 B
Marketcap
$3.11
Share price
-1.27%
Change (1 day)
62.06%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -S$10.61 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are S$45.66 Million. In 2023 the company made an earning of S$15.63 Million, an increase over its 2022 earnings that were of -S$15.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$10.61 Million-167.84%
2023 S$15.63 M-199.05%
2022 -S$15.79 Million-40.38%
2021 -S$26.47 Million-732.31%
2020 S$4.18 M-130.53%
2019 -S$13.72 Million189.85%
2018 -S$4.74 Million-95.29%
2017 -S$0.11 Billion308.12%
2016 -S$24.62 Million-32.37%
2015 -S$36.4 Million10.11%
2014 -S$33.06 Million-7.59%
2013 -S$35.78 Million
2011 -S$41.43 Million-19.39%
2010 -S$51.39 Million20.87%
2009 -S$42.52 Million32.26%
2008 -S$32.15 Million-5.46%
2007 -S$34 Million
2004 -S$0.23 Million12.35%
2003 -S$0.2 Million-11.1%
2002 -S$0.23 Million-57.03%
2001 -S$0.52 Million1.03%
2000 -S$0.51 Million-53.22%
1999 -S$1.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$38.24 Million 270.66%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.68 B-6,716.40%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.23 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.38 Billion 3,534.96%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel